Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe
EUnetHTA 21 launches Open Call for JSC
EUnetHTA 21 is launching the first Open Call for applications from the pharmaceutical industry for four Joint Scientific Consultations (JSC), starting in January 2022. These
EUnetHTA 21 – first Stakeholder Kick-Off Meeting
EUnetHTA 21 Secretariat is pleased to announced that the first EUnetHTA 21 Stakeholder Kick-Off Meeting is scheduled, online, for 03.12.2021 at 10:30-12:00 CET. The meeting will entail a high-level focus
EUnetHTA 21 JSC – open calls
As one of the first milestones of EUnetHTA 21, we will soon launch the first open call to pharmaceutical industry for applications for the upcoming
European HTA agencies launch the Heads of Agencies Group (HAG)
On 29 September 2021, the heads of 19 European HTA agencies came together and inaugurated a new HTA-focused collaborative network for high-level strategic exchange and
EUnetHTA 21
On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work
Future Model of Cooperation (FMC) – White Paper
EUnetHTA has become synonymous with HTA in Europe, a trademark, in fact, that stands for a community of professionals dedicated to continuously improve the standards
Joint HTA Work
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Scientific Consultations, Parallel Consultations, and Post Launch Evidence Generation (PLEG). Find out more here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
